OAKTREE CAPITAL MANAGEMENT LP - NEUROCRINE BIOSCIENCES INC ownership

NEUROCRINE BIOSCIENCES INC's ticker is and the CUSIP is 64125CAD1. A total of 32 filers reported holding NEUROCRINE BIOSCIENCES INC in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
OAKTREE CAPITAL MANAGEMENT LP ownership history of NEUROCRINE BIOSCIENCES INC
ValueSharesWeighting
Q2 2021$2,693,000
-22.1%
2,000,000
-11.1%
0.04%
-44.6%
Q4 2019$3,456,000
+0.7%
2,250,000
-10.0%
0.06%
-3.0%
Q3 2019$3,431,000
-13.2%
2,500,000
-16.7%
0.07%
-9.5%
Q2 2019$3,952,000
-55.1%
3,000,000
-53.8%
0.07%
-55.7%
Q1 2019$8,800,000
-42.0%
6,500,000
-26.9%
0.17%
-18.1%
Q3 2018$15,184,000
-11.0%
8,895,000
-24.7%
0.20%
-14.6%
Q2 2018$17,066,00011,805,0000.24%
Other shareholders
NEUROCRINE BIOSCIENCES INC shareholders Q3 2023
NameSharesValueWeighting ↓
CSS LLC/IL 15,659,000$23,207,6871.52%
SONA ASSET MANAGEMENT (US) LLC 17,500,000$26,317,9521.09%
TENOR CAPITAL MANAGEMENT Co., L.P. 26,765,000$40,113,0990.86%
Warberg Asset Management LLC 1,271,000$1,885,8460.38%
SSI INVESTMENT MANAGEMENT LLC 2,296,000$3,406,1160.28%
Paloma Partners Management Co 3,125,000$4,694,5900.16%
FRANKLIN RESOURCES INC 54,750,000$81,769,1250.04%
Rock Springs Capital Management LP 1,000,000$1,497,9500.04%
LORD, ABBETT & CO. LLC 4,666,000$6,9220.03%
D. E. Shaw & Co., Inc. 14,351,000$21,373,1970.02%
View complete list of NEUROCRINE BIOSCIENCES INC shareholders